Overview

Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy of DE-089 ophthalmic solution in patients with dry eye will be evaluated in comparison with sodium hyaluronate ophthalmic solution.
Phase:
N/A
Details
Lead Sponsor:
Santen Pharmaceutical Co., Ltd.
Treatments:
Hyaluronic Acid
Ophthalmic Solutions
Pharmaceutical Solutions